Bilateral breast cancers (Q38184906)

30 August 2017

title

Bilateral breast cancers (English)

1 reference

30 August 2017

1

Steven A Narod

1 reference

30 August 2017

language of work or name

English

0 references

publication date

4 February 2014

1 reference

Nature Reviews Clinical Oncology

30 August 2017

published in

1 reference

30 August 2017

volume

11

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

157-166

1 reference

When is contralateral mastectomy warranted in unilateral breast cancer?

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Contralateral risk-reducing mastectomy in sporadic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Tumor self-seeding by circulating cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Incidence and Prognosis of Synchronous and Metachronous Bilateral Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Concordance in histological and biological parameters between first and second primary breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Early detection of second breast cancers improves prognosis in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Second primary breast cancer occurrence according to hormone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Ten genes for inherited breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Testing for CHEK2 in the cancer genetics clinic: ready for prime time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Polygenic susceptibility to breast cancer: current state-of-the-art

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Reproductive history and risk of second primary breast cancer: the WECARE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Body mass index and risk of second primary breast cancer: the WECARE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Mammographic density and breast cancer risk: current understanding and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Change of mammographic density predicts the risk of contralateral breast cancer--a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Letrozole in the extended adjuvant setting: MA.17

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Bilateral synchronous breast cancer and HER-2/neu overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Risk of a Second Breast Cancer Associated with Hormone-Receptor and HER2/neu Status of the First Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Concordance of the hormone receptors and correlation of HER-2/neu overexpression of the metachronous cancers of contralateral breasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Paired distribution of molecular subtypes in bilateral breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

A comparison of bilateral breast cancers in BRCA carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: Possible role of host factors and survival bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Breast cancer, stem/progenitor cells and the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Global changes in the mammary epigenome are induced by hormonal cues and coordinated by Ezh2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

A breast cancer prediction model incorporating familial and personal risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Breast cancer in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Clinical Management Factors Contribute to the Decision for Contralateral Prophylactic Mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Occult Malignancy in Patients Undergoing Contralateral Prophylactic Mastectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Relationship of Breast Magnetic Resonance Imaging to Outcome After Breast-Conservation Treatment With Radiation for Women With Early-Stage Invasive Breast Carcinoma or Ductal Carcinoma in Situ

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Risk factors and age-incidence relationships for contralateral breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Risk of contralateral breast cancer: associations with factors related to initial breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

TP53 mutations in synchronous and metachronous bilateral breast carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2014.3

Epidemiology of contralateral breast cancer

31 March 2020

1 reference

12 December 2020

Is steroid receptor profile in contralateral breast cancer a marker of independence of the corresponding primary tumour?

1 reference

12 December 2020

A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriers

1 reference

12 December 2020

A Model for Breast Cancer Risk Based on Stem-Cell Theory

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCLINONC.2014.3

1 reference

Dimensions Publication ID

30 August 2017

1052897819

0 references

1 reference